GEFITINIB for Lung neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 779 adverse event reports in the FDA FAERS database where GEFITINIB was used for Lung neoplasm malignant.

Most Reported Side Effects for GEFITINIB

Side Effect	Reports	%	Deaths	Hosp.
Malignant neoplasm progression	1,651	35.2%	217	160
Drug resistance	1,228	26.1%	95	115
Death	590	12.6%	589	50
Diarrhoea	393	8.4%	73	114
Rash	318	6.8%	48	66
Metastases to central nervous system	306	6.5%	51	49
Acquired gene mutation	250	5.3%	36	21
Disease progression	244	5.2%	33	16
Drug ineffective	197	4.2%	33	39
Off label use	166	3.5%	37	40
Decreased appetite	163	3.5%	44	55
Metastases to bone	147	3.1%	19	14
Nausea	139	3.0%	24	41
Pleural effusion	137	2.9%	34	52
Fatigue	129	2.8%	31	28